Search
for
Sort by
Research 841–870 of 895
- Nivolumab-Induced Alopecia Areata: A Case Report and Literature Review
- Frontal Fibrosing Alopecia Quality of Life Index: A Validated Disease-Specific Questionnaire Involving Women
- Beyond health-related quality of life: initial psychometric validation of a new scale for addressing the gap in assessing the full range of alopecia areata psychosocial burden
- Diagnostic Accuracy of Trichoscopy in Trichotillomania: A Systematic Review
- Janus kinase inhibitors for alopecia areata
- Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata
- Treatment options and emotional well-being in patients with rosacea: An unsupervised machine learning analysis of over 200,000 posts
- Autosomal recessive monilethrix: Novel variants of the <i>DSG4</i> gene in three Chinese families
- Scanning electron microscopy of murine skin ultrathin sections and cultured keratinocytes
- Correlation of clinical and trichoscopy features with the degree of histologic inflammation in lichen planopilaris and frontal fibrosing alopecia in a cross-sectional study
- Permanent chemotherapy-induced alopecia after hematopoietic stem cell transplantation treated with low-dose oral minoxidil
- A Novel Atypical Presentation of Frontal Fibrosing Alopecia Involving the Frontoparietal Scalp
- Differentiation of frontal fibrosing alopecia and Lichen planopilaris on trichoscopy: A comprehensive review
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata
- The impact, prevalence, and association of different forms of hair loss among individuals with anxiety disorder: Systematic review and meta-analysis
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Association of resilience and perceived stress in patients with alopecia areata: A cross-sectional study
- Unusual loss of body hair in childhood: Trichotillomania or alopecia
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Correlation between increased total serum IgE levels and clinical features in alopecia areata patients
- The first 20 years of skin of color dermatology: An era of advancements in skin, hair, and nail disorders
- Assessment of Alopecia Areata Disease Severity in Pediatric Patients
- A new era for alopecia areata: New treatments and improved knowledge of the condition
- Type 2 Diabetes Mellitus and Demodex folliculorum Infestation: A Cross-Sectional Study in Peruvian Patients
- Content validity of five single‐item instruments in adolescents with alopecia areata
- Dermatologists’ Perspectives and Real-World Assessment of Alopecia Areata Severity, Burden, and Healthcare Resource Utilization in Adults in the United Arab Emirates
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care